{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:17:49Z","timestamp":1785352669843,"version":"3.55.0"},"reference-count":99,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health Research Institute, Taiwan","award":["NHRI-EX111-11117PI"],"award-info":[{"award-number":["NHRI-EX111-11117PI"]}]},{"name":"National Health Research Institute, Taiwan","award":["109-2926-1010-504"],"award-info":[{"award-number":["109-2926-1010-504"]}]},{"name":"National Health Research Institute, Taiwan","award":["110-2628-B-A49A-507"],"award-info":[{"award-number":["110-2628-B-A49A-507"]}]},{"name":"National Health Research Institute, Taiwan","award":["109-2628-B-010-010"],"award-info":[{"award-number":["109-2628-B-010-010"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["NHRI-EX111-11117PI"],"award-info":[{"award-number":["NHRI-EX111-11117PI"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["109-2926-1010-504"],"award-info":[{"award-number":["109-2926-1010-504"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["110-2628-B-A49A-507"],"award-info":[{"award-number":["110-2628-B-A49A-507"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["109-2628-B-010-010"],"award-info":[{"award-number":["109-2628-B-010-010"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["NHRI-EX111-11117PI"],"award-info":[{"award-number":["NHRI-EX111-11117PI"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["109-2926-1010-504"],"award-info":[{"award-number":["109-2926-1010-504"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["110-2628-B-A49A-507"],"award-info":[{"award-number":["110-2628-B-A49A-507"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["109-2628-B-010-010"],"award-info":[{"award-number":["109-2628-B-010-010"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["NHRI-EX111-11117PI"],"award-info":[{"award-number":["NHRI-EX111-11117PI"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["109-2926-1010-504"],"award-info":[{"award-number":["109-2926-1010-504"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["110-2628-B-A49A-507"],"award-info":[{"award-number":["110-2628-B-A49A-507"]}]},{"name":"Ministry of Science and Technology, Taipei, Taiwan","award":["109-2628-B-010-010"],"award-info":[{"award-number":["109-2628-B-010-010"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths globally. The risk factors for HCC include chronic hepatitis B and C virus infections, excessive alcohol consumption, obesity, metabolic disease, and aflatoxin exposure. In addition to these viral and environmental risk factors, individual genetic predisposition is a major determinant of HCC risk. Familial clustering of HCC has been observed, and a hereditary factor likely contributes to the risk of HCC development. The familial aggregation may depend on a shared environment and genetic background as well as the interactions of environmental and genetic factors. Genome-wide association studies (GWASs) are one of the most practical tools for mapping the patterns of inheritance for the most common form of genomic variation, single nucleotide polymorphisms. This approach is practical for investigating genetic variants across the human genome, which is affected by thousands of common genetic variants that do not follow Mendelian inheritance. This review article summarizes the academic knowledge of GWAS-identified genetic loci and their association with HCC. We summarize the GWASs in accordance with various chronic hepatitis virus infection statuses. This genetic profiling could be used to identify candidate biomarkers to refine HCC screening and management by enabling individual risk-based personalization and stratification. A more comprehensive understanding of the genetic mechanisms underlying individual predisposition to HCC may lead to improvements in the prevention and early diagnosis of HCC and the development of effective treatment strategies.<\/jats:p>","DOI":"10.3390\/v15020559","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T04:58:23Z","timestamp":1676869103000},"page":"559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection"],"prefix":"10.3390","volume":"15","author":[{"given":"Tsai-Hsuan","family":"Yang","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, 155 Li-Nong Street, Section Peitou, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Chan","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, 155 Li-Nong Street, Section Peitou, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Jiun","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, 155 Li-Nong Street, Section Peitou, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-3060","authenticated-orcid":false,"given":"Yu-Han","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, 155 Li-Nong Street, Section Peitou, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0222-2251","authenticated-orcid":false,"given":"Mei-Hsuan","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, 155 Li-Nong Street, Section Peitou, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","unstructured":"Global Burden of Disease 2019 Cancer Collaboration (2022). Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol., 8, 420\u2013444."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978\u20132012","volume":"147","author":"Petrick","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of Hepatocellular Carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1053\/j.gastro.2021.08.006","article-title":"Potential Impact of Time Trend of Lifestyle Risk Factors on Burden of Major Gastrointestinal Cancers in China","volume":"161","author":"Wu","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.30447","article-title":"Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population","volume":"140","author":"Dai","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis","volume":"8","author":"Georges","year":"2020","journal-title":"Lancet Global Health."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinomoa and hepatitis B virus: A prospective study of 22 707 men in Taiwan","volume":"318","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/djn243","article-title":"Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma","volume":"100","author":"Yang","year":"2008","journal-title":"JNCI"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cgh.2018.04.064","article-title":"Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients","volume":"17","author":"Hu","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1038\/s41598-017-14747-5","article-title":"Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(95)90400-X","article-title":"HCV-associated liver cancer without cirrhosis","volume":"345","author":"Pisi","year":"1995","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C Virus Infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: Incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"New Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gut.2010.220889","article-title":"Community and personal risk factors for hepatitis C virus infection: A survey of 23 820 residents in Taiwan in 1991-2","volume":"60","author":"Lee","year":"2011","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2010.29.1500","article-title":"Hepatitis C Virus Seromarkers and Subsequent Risk of Hepatocellular Carcinoma: Long-Term Predictors From a Community-Based Cohort Study","volume":"28","author":"Yang","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ijc.28753","article-title":"Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma","volume":"135","author":"Lee","year":"2014","journal-title":"Int. J. Cancer."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1038\/s41424-018-0050-3","article-title":"A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements","volume":"9","author":"Lin","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/apt.16524","article-title":"Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals","volume":"54","author":"Koshiol","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/ijc.33051","article-title":"Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies","volume":"147","author":"Petrick","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","article-title":"Hepatocellular carcinoma in the setting of alcohol-related liver disease","volume":"70","author":"Nahon","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: A comprehensive dose\u2013response meta-analysis","volume":"112","author":"Bagnardi","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/1055-9965.EPI-15-0961","article-title":"Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B\u2013Related Hepatocellular Carcinoma","volume":"25","author":"Liu","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"Hassan","year":"2002","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/80.5.1106","article-title":"Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and interventions","volume":"80","author":"Williams","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hep.510240108","article-title":"Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma","volume":"24","author":"Chen","year":"1996","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","article-title":"Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis","volume":"48","author":"Liu","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.30782","article-title":"Aflatoxin B1exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers","volume":"141","author":"Chu","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2018.02.010","article-title":"Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption","volume":"94","author":"Chu","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2018.5639","article-title":"Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011\u20132015","volume":"5","author":"Islami","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2008.03.073","article-title":"Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B\/C Infection: A Follow-up Study in Taiwan","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hep.21208","article-title":"Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection","volume":"43","author":"Lai","year":"2006","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Huang, Y.-H., Chan, C., Lee, H.-W., Huang, C., Chen, Y.-J., Liu, P.-C., Lu, S.-N., Huang, J.-F., Yu, M.-L., and Koshiol, J. (2022). Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma. Clin. Gastroenterol. Hepatol., online ahead of print.","DOI":"10.1016\/j.cgh.2022.01.046"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.1840130303","article-title":"Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma","volume":"13","author":"Chen","year":"1991","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1008989103809","article-title":"A case\u2013control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study","volume":"10","author":"Donato","year":"1999","journal-title":"Cancer Causes Control."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2008.08.016","article-title":"The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States","volume":"50","author":"Hassan","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ijc.2910510402","article-title":"Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case-Control study in Fukuoka, Japan","volume":"51","author":"Tanaka","year":"1992","journal-title":"Int. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12072-013-9447-y","article-title":"Familial clustering of hepatocellular carcinoma in HBsAg-positive patients in the United States","volume":"7","author":"Tong","year":"2013","journal-title":"Hepatol. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.2910450205","article-title":"A case-control study of hepatocellular carcinoma in osaka, Japan","volume":"45","author":"Tsukuma","year":"1990","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2005.04.014","article-title":"A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection","volume":"229","author":"Zhu","year":"2005","journal-title":"Cancer Lett."},{"key":"ref_53","first-page":"209","article-title":"Family history and the risk of liver, gallbladder, and pancreatic cancer","volume":"3","author":"Negri","year":"1994","journal-title":"Cancer Epidemiology Biomarkers Prev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/92.14.1159","article-title":"Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives","volume":"92","author":"Yu","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.24794","article-title":"Family history of liver cancer and hepatocellular carcinoma","volume":"55","author":"Turati","year":"2012","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/gut.52.4.592","article-title":"Familial liver and gall bladder cancer: A nationwide epidemiological study from Sweden","volume":"52","author":"Hemminki","year":"2003","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2013.04.043","article-title":"Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma","volume":"11","author":"Loomba","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v18.i21.2661","article-title":"Family history influences the early onset of hepatocellular carcinoma","volume":"18","author":"Park","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2009.11.015","article-title":"Risk of HCC: Genetic heterogeneity and complex genetics","volume":"52","author":"Dragani","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","article-title":"Genomewide Association Studies and Assessment of the Risk of Disease","volume":"363","author":"Manolio","year":"2010","journal-title":"New Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1002\/cncr.30851","article-title":"Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/JHC.S321919","article-title":"Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese","volume":"8","author":"Mai","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zeng, Z., the HBVstudy consortium, Liu, H., Xu, H., Lu, H., Yu, Y., Xu, X., Yu, M., Zhang, T., and Tian, X. (2021). Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression. BMC Med Genom., 14.","DOI":"10.1186\/s12920-021-00907-0"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng.638","article-title":"Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers","volume":"42","author":"Zhang","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","article-title":"The kinesin KIF1B\u03b2 acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor","volume":"22","author":"Schlisio","year":"2008","journal-title":"Genes Dev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1158\/1078-0432.CCR-17-2537","article-title":"Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma","volume":"24","author":"Li","year":"2018","journal-title":"Clin Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chan, K.Y.-K., Wong, C.-M., Kwan, J.S.-H., Lee, J.M.-F., Cheung, K.W., Yuen, M.F., Lai, C.-L., Poon, R.T.-P., Sham, P.C., and Ng, I.O.-L. (2011). Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection. PLOS ONE, 6.","DOI":"10.1371\/journal.pone.0028798"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.-X., Foo, J.N., McLaren, P.J., Li, Z., and Yang, J. (2012). GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers. PLOS Genet., 8.","DOI":"10.1371\/journal.pgen.1002791"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.2483","article-title":"Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus\u2013related hepatocellular carcinoma","volume":"45","author":"Jiang","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_71","first-page":"695","article-title":"A high-resolution HLA imputation system for the Taiwanese population: A study of the Taiwan Biobank","volume":"20","author":"Huang","year":"2020","journal-title":"Pharm. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/apt.15887","article-title":"Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: A study from Taiwan Biobank","volume":"52","author":"Huang","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3892\/ol.2015.3958","article-title":"Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study","volume":"11","author":"Qu","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-\u03b1 and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/j.gastro.2010.06.071","article-title":"ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy\u2014A Genome-Wide Study of Japanese HCV Virus Patients","volume":"139","author":"Ochi","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08825","article-title":"ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C","volume":"464","author":"Fellay","year":"2010","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.876","article-title":"Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers","volume":"43","author":"Miki","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1038\/srep17030","article-title":"Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/hepr.12393","article-title":"Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy","volume":"45","author":"Hiramatsu","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2017.01.041","article-title":"Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection","volume":"152","author":"Matsuura","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/hep.29531","article-title":"Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study","volume":"67","author":"Lee","year":"2018","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jvh.13550","article-title":"Genetic variants associated with serum alanine aminotransferase levels among patients with hepatitis C virus infection: A genome-wide association study","volume":"28","author":"Liu","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jhep.2012.12.024","article-title":"A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region","volume":"58","author":"Urabe","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1470-2045(21)00603-3","article-title":"Common genetic variation in alcohol-related hepatocellular carcinoma: A case-control genome-wide association study","volume":"23","author":"Caruso","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/jgh3.12682","article-title":"Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study","volume":"5","author":"Wang","year":"2021","journal-title":"JGH Open"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41588-020-0640-3","article-title":"Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases","volume":"52","author":"Ishigaki","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Kawaguchi, T., Shima, T., Mizuno, M., Mitsumoto, Y., Umemura, A., Kanbara, Y., Tanaka, S., Sumida, Y., Yasui, K., and Takahashi, M. (2018). Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0185490"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrg.2016.27","article-title":"Developing and evaluating polygenic risk prediction models for stratified disease prevention","volume":"17","author":"Chatterjee","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ebiom.2016.11.031","article-title":"Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment","volume":"15","author":"Huang","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2016.07.004","article-title":"Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution","volume":"65","author":"Nault","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Kato, K., Shimada, N., Atsukawa, M., Abe, H., Itokawa, N., Matsumoto, Y., Agata, R., and Tsubota, A. (2019). Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219022"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/jir.2019.0013","article-title":"STOP-HCV Consortium Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients","volume":"39","author":"Pedergnana","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Corma-G\u00f3mez, A., Mac\u00edas, J., Rivero, A., Rivero-Juarez, A., Santos, I.D.L., Reus-Ba\u00f1uls, S., Morano, L., Merino, D., Palacios, R., and Galera, C. (2021). A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure. Diagnostics, 11.","DOI":"10.3390\/diagnostics11081501"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide","volume":"142","author":"Franceschi","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrg3523","article-title":"Bringing genome-wide association findings into clinical use","volume":"14","author":"Manolio","year":"2013","journal-title":"Nat. Rev. Genet."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/559\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:40:02Z","timestamp":1760121602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":99,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["v15020559"],"URL":"https:\/\/doi.org\/10.3390\/v15020559","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}